|
|
|
|
NARFE January
While the start of a new year is a time to look ahead, it's also an opportunity to reflect on the accomplishments from the previous year. We couldn't be prouder about NARFE's incredible fundraising achievement — more than $15 million through Walk to End Alzheimer's®! This is an amazing milestone, and we are incredibly grateful. The Alzheimer's Association® invests these critical dollars in cutting-edge research projects that hold the most potential to help people today and change the trajectory of this devastating disease. Plus, funds raised also support care and support programs, such as the Alzheimer's Association 24/7 Helpline (800.272.3900), local face-to-face support groups and online support communities, and education programs and online courses. You make this possible! Thanks to NARFE's inspiring fundraising efforts, we're making progress in the fight against Alzheimer's. We appreciate you and all you do to help end Alzheimer's. Thank you, NARFE members, for your commitment to our vision of a world without Alzheimer's and all other dementia.
|
|
|
Five important things we learned about Alzheimer's in 2022
Last year was an exciting time in the field of Alzheimer's and dementia research. On our blog, we look back at progress made in 2022, including discoveries into the causes, risk factors and treatment of Alzheimer's and other dementia. Learn more.
|
|
|
|
|
Alzheimer's Association welcomes FDA approval of lecanemab
The Alzheimer's Association enthusiastically welcomes the U.S. Food and Drug Administration's (FDA) action to grant the accelerated approval of lecanemab (Leqembi™) for the treatment of patients in the mild cognitive impairment (MCI) or mild dementia stage of Alzheimer's disease and with confirmation of beta-amyloid. The Association also renews the urgent call for the Centers for Medicare & Medicaid Services to cover FDA-approved Alzheimer's treatments. Learn more.
|
|
|
|
|
Adult day centers can benefit people living with Alzheimer's and their caregivers
Adult day centers offer people living with Alzheimer's or another dementia the opportunity to be social and participate in activities in a safe environment. Caregivers can also benefit from a much-needed break. Learn more.
|
|
|
|
|
Activities can provide meaningful benefits and reduce stress
People living with Alzheimer's disease don't have to give up the activities that they love. In addition to enhancing quality of life, activities can reduce behaviors like wandering or agitation and can help reduce caregiver stress. Learn more.
|
|
|
|
|
View Past Issues
|
|
|
|
|
NARFE 2025 Goal: $16 Million
|
|
|
|
24/7 Helpline: 1-800-272-3900
|
|
